InsiderTrades

Form 4 for CAPR CAPRICOR THERAPEUTICS, INC.

Accepted 2025-03-04 00:00:00 ET · period of report 2025-03-03 · accession 0001415889-25-006736 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-03-04 2025-03-03 CAPR Litvack Frank Dir F - Tax $13.67 -2,543 129.8K -2% -$34.8K
D 2025-03-04 2025-03-03 CAPR Litvack Frank Dir M - OptEx $1.39 +25.0K 132.4K +23% +$34.8K
D 2025-03-04 2025-03-03 CAPR Litvack Frank Dir M - OptEx $0.00 -25.0K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-03-03 F D 2,543 $13.67 129,839 D — — (F1) Represents a "net exercise" of outstanding stock options. These shares were withheld by the Issuer for payment of the exercise price, based on the closing market price of the Issuer's common stock on March 3, 2025 of $13.67. The options would otherwise expire on March 3, 2025, pursuant to their terms.
2 Common Common Stock 2025-03-03 M A 25,000 $1.39 132,382 D — —
3 Derivative Stock Option (Right to Buy) 2025-03-03 M D 25,000 $0.00 0 D $1.39 · — to 2025-03-03 25,000 Common Stock (F3) This option was granted on March 3, 2015 and was previously reported as covering 250,000 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020. (F4) Shares vested 1/48th on the first day of each month commencing April 1, 2015.